Viewing Study NCT00935792


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2025-12-27 @ 12:26 AM
Study NCT ID: NCT00935792
Status: COMPLETED
Last Update Posted: 2017-09-26
First Post: 2009-07-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: Mayo Clinic
Organization: